361 related articles for article (PubMed ID: 23873756)
1. Electronic health record-based triggers to detect potential delays in cancer diagnosis.
Murphy DR; Laxmisan A; Reis BA; Thomas EJ; Esquivel A; Forjuoh SN; Parikh R; Khan MM; Singh H
BMJ Qual Saf; 2014 Jan; 23(1):8-16. PubMed ID: 23873756
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of Electronic Health Record-based Triggers to Detect Delays in Follow-up of Abnormal Lung Imaging Findings.
Murphy DR; Thomas EJ; Meyer AN; Singh H
Radiology; 2015 Oct; 277(1):81-7. PubMed ID: 25961634
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Murphy DR; Meyer AND; Vaghani V; Russo E; Sittig DF; Wei L; Wu L; Singh H
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):90-98. PubMed ID: 28804030
[TBL] [Abstract][Full Text] [Related]
4. Computerized Triggers of Big Data to Detect Delays in Follow-up of Chest Imaging Results.
Murphy DR; Meyer AN; Bhise V; Russo E; Sittig DF; Wei L; Wu L; Singh H
Chest; 2016 Sep; 150(3):613-20. PubMed ID: 27178786
[TBL] [Abstract][Full Text] [Related]
5. Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.
Murphy DR; Wu L; Thomas EJ; Forjuoh SN; Meyer AN; Singh H
J Clin Oncol; 2015 Nov; 33(31):3560-7. PubMed ID: 26304875
[TBL] [Abstract][Full Text] [Related]
6. Electronic Detection of Delayed Test Result Follow-Up in Patients with Hypothyroidism.
Meyer AND; Murphy DR; Al-Mutairi A; Sittig DF; Wei L; Russo E; Singh H
J Gen Intern Med; 2017 Jul; 32(7):753-759. PubMed ID: 28138875
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of delayed clinician response to elevated prostate-specific antigen values.
Nepple KG; Joudi FN; Hillis SL; Wahls TL
Mayo Clin Proc; 2008 Apr; 83(4):439-45. PubMed ID: 18380989
[TBL] [Abstract][Full Text] [Related]
8. Electronic Triggers to Identify Delays in Follow-Up of Mammography: Harnessing the Power of Big Data in Health Care.
Murphy DR; Meyer AND; Vaghani V; Russo E; Sittig DF; Wei L; Wu L; Singh H
J Am Coll Radiol; 2018 Feb; 15(2):287-295. PubMed ID: 29102539
[TBL] [Abstract][Full Text] [Related]
9. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
10. A population-based audit of the clinical use of faecal occult blood testing in primary care for colorectal cancer.
Gillberg A; Ericsson E; Granstrom F; Olsson LI
Colorectal Dis; 2012 Sep; 14(9):e539-46. PubMed ID: 22738077
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and diagnostic errors: time for a new paradigm.
Schiff GD
BMJ Qual Saf; 2014 Jan; 23(1):1-3. PubMed ID: 24050984
[No Abstract] [Full Text] [Related]
12. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
13. Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
Hazazi R; Rozen P; Leshno M; Levi Z; Samuel Z; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2010 Feb; 31(4):523-33. PubMed ID: 19925498
[TBL] [Abstract][Full Text] [Related]
14. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
15. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
Schröder FH; Bangma CH; Roobol MJ
Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
[TBL] [Abstract][Full Text] [Related]
16. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
17. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods Study.
Danforth KN; Hahn EE; Slezak JM; Chen LH; Li BH; Munoz-Plaza CE; Luong TQ; Harrison TN; Mittman BS; Sim JJ; Singh H; Kanter MH
Am J Kidney Dis; 2019 Nov; 74(5):589-600. PubMed ID: 31324445
[TBL] [Abstract][Full Text] [Related]
19. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
[TBL] [Abstract][Full Text] [Related]
20. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
